OTCMKTS:TRUMY Terumo - TRUMY Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Terumo Co. Please log in to your account or sign up in order to add this asset to your watchlist. $29.05 +0.01 (+0.03%) (As of 02/6/2023 12:00 AM ET) Add Compare Share Share Today's Range$28.96▼$29.2450-Day Range$26.67▼$29.9052-Week Range$26.58▼$37.00Volume28,219 shsAverage Volume44,647 shsMarket Capitalization$21.72 billionP/E Ratio30.90Dividend Yield0.69%Price TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest Terumo MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth25.00%From $1.16 to $1.45 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.34 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Terumo. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of Terumo have been sold short.Short Interest Ratio / Days to CoverTerumo has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Terumo has recently decreased by 93.21%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldTerumo has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthTerumo does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Terumo is 21.28%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Terumo will have a dividend payout ratio of 13.79% next year. This indicates that Terumo will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRUMY. Previous Next 1.1 News and Social Media Coverage News SentimentTerumo has a news sentiment score of -1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Terumo this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added Terumo to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Terumo insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.01% of the stock of Terumo is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Terumo are expected to grow by 25.00% in the coming year, from $1.16 to $1.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Terumo is 30.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Terumo is 30.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 118.76.Price to Book Value per Share RatioTerumo has a P/B Ratio of 2.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Terumo (OTCMKTS:TRUMY) StockTerumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.Read More Receive TRUMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. Email Address TRUMY Stock News HeadlinesJanuary 31, 2023 | nbcnews.comTrump kicks off his 2024 campaign: 'We are at the brink of World War III'January 30, 2023 | time.comTrump Delivers Bitter Speech Filled With Falsehoods in New HampshireFebruary 6, 2023 | Investing Trends (Ad)New "Vertical" Technology Solves Solar Power's Major FlawEven conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive...Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power.January 27, 2023 | forbes.comTrump Reinstated To Facebook And InstagramJanuary 27, 2023 | nytimes.comOMG. Trump Has Started Texting.January 27, 2023 | nypost.comTrump is now texting after avoiding messages for decades: sourcesJanuary 26, 2023 | usatoday.comTrump declares himself winner of his own golf club championship – despite missing a roundJanuary 25, 2023 | nypost.comTrump preparing to ditch Truth Social so he can return to Twitter, Facebook: reportFebruary 6, 2023 | Investing Trends (Ad)"TAKE THAT, CHINA!" USA Gains in EV Battery Arms RaceDid you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. January 24, 2023 | nbcnews.comTrump mistook photo of E. Jean Carroll for ex-wife during deposition in rape allegation lawsuitJanuary 18, 2023 | msn.comBank of Japan Doves Propel Tokyo Shares UpJanuary 16, 2023 | businessinsider.comTrump used his deposition in a defamation case to boast, complain, insult Joe Biden, and threaten to sue the attorney questioning himJanuary 15, 2023 | washingtonpost.comTrump campaign officials got subpoena asking new questions about Jan. 6January 14, 2023 | nypost.comTrump’s pardons: Full list of clemencies granted during his presidencyJanuary 12, 2023 | finanznachrichten.deFinancialnewsmedia.com: Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029January 12, 2023 | benzinga.comGlobal Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029January 5, 2023 | finance.yahoo.comGlobal PTA Balloon Catheter Market Report 2022 to 2030: Featuring Key Players Medtronic, Terumo, Cardinal Health, Boston Scientific and OthersJanuary 2, 2023 | abcnews.go.com6 years of Trump tax documents released by House Ways and Means CommitteeNovember 13, 2022 | seekingalpha.comTerumo Corporation 2022 Q3 - Results - Earnings Call PresentationNovember 11, 2022 | usatoday.comJan. 6 committee subpoenas Donald Trump in investigation of Capitol riotSeptember 18, 2022 | usatoday.comDo Trump's attacks on DOJ cross a line? Comments raise concern about illegal incitement.September 13, 2022 | usatoday.comClassified documents were mingled with magazines and clothes at Trump's Mar-a-Lago clubSeptember 7, 2022 | benzinga.comDigital Diabetes Management Market to Reach US$ 29.6 Billion, Globally, by 2027 at 22.6% CAGR | Exclusive Report by IMARC GroupSeptember 7, 2022 | marketwatch.comDisposable Plunger Market 2022-2027: Global Size, Share, Emerging Trends, Demand, Revenue and Forecast Study | 106 Report PagesAugust 31, 2022 | marketwatch.comMedical Supplies Market Size and Share 2022 Research Report by Industry Trends, Recent Developments, Demand and Forecast to 2028August 26, 2022 | ca.finance.yahoo.comJapan's Nikkei snaps 5-day slide ahead of Jackson Hole conferenceAugust 19, 2022 | marketwatch.comInterventional Cardiology Market Size Is Expected To Grow At A CAGR Of 6.8% During Assessment Period 2022-2025 | 99 Report PagesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TRUMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. Email Address TRUMY Company Calendar Today2/06/2023Fiscal Year End3/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical & hospital equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TRUMY Previous SymbolNASDAQ:TRUMY CUSIPN/A CIK1446672 Webwww.terumo.co.jp Phone(133) 374-8111Fax813-3374-8399Employees28,294Year Founded1964Profitability EPS (Most Recent Fiscal Year)$0.94 Trailing P/E Ratio30.90 Forward P/E Ratio25.04 P/E GrowthN/ANet Income$790.44 million Net Margins11.45% Pretax MarginN/A Return on Equity8.26% Return on Assets5.67% Debt Debt-to-Equity Ratio0.20 Current Ratio3.22 Quick Ratio2.03 Sales & Book Value Annual Sales$6.27 billion Price / Sales3.47 Cash Flow$1.73 per share Price / Cash Flow16.77 Book Value$11.86 per share Price / Book2.45Miscellaneous Outstanding Shares747,680,000Free FloatN/AMarket Cap$21.72 billion OptionableNot Optionable Beta0.49 Social Links Key ExecutivesShinjiro SatoPresident, CEO & Representative DirectorNaoki MutoChief Financial & Accounting OfficerKazuhisa SenshuChief Clinical & Regulatory Affairs OfficerKatsuya TakeuchiChief Information Officer & Executive OfficerShouji HatanoDirector, Head-Compliance & Legal AffairsKey CompetitorsHenry ScheinNASDAQ:HSICBioMarin PharmaceuticalNASDAQ:BMRNH. Lundbeck A/SOTCMKTS:HLUYYSTERISNYSE:STEAlign TechnologyNASDAQ:ALGNView All Competitors TRUMY Stock - Frequently Asked Questions How have TRUMY shares performed in 2023? Terumo's stock was trading at $28.1850 at the start of the year. Since then, TRUMY shares have increased by 3.1% and is now trading at $29.05. View the best growth stocks for 2023 here. Are investors shorting Terumo? Terumo saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 1,500 shares, a drop of 93.2% from the December 31st total of 22,100 shares. Based on an average daily volume of 118,700 shares, the short-interest ratio is currently 0.0 days. View Terumo's Short Interest. Is Terumo a good dividend stock? Terumo (OTCMKTS:TRUMY) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.69%. The dividend payout ratio is 21.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TRUMY will have a dividend payout ratio of 13.79% next year. This indicates that the company will be able to sustain or increase its dividend. What is Terumo's stock symbol? Terumo trades on the OTCMKTS under the ticker symbol "TRUMY." How do I buy shares of Terumo? Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Terumo's stock price today? One share of TRUMY stock can currently be purchased for approximately $29.05. How much money does Terumo make? Terumo (OTCMKTS:TRUMY) has a market capitalization of $21.72 billion and generates $6.27 billion in revenue each year. The company earns $790.44 million in net income (profit) each year or $0.94 on an earnings per share basis. How many employees does Terumo have? The company employs 28,294 workers across the globe. How can I contact Terumo? Terumo's mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The official website for the company is www.terumo.co.jp. The company can be reached via phone at (133) 374-8111, via email at kouhou_terumo01@terumo.co.jp, or via fax at 813-3374-8399. This page (OTCMKTS:TRUMY) was last updated on 2/6/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.